Author | Robert L. Fine, MD | OncLive

Author | Robert L. Fine, MD

Articles

Dr. Fine on GTX in Inoperable Pancreatic Cancer

March 05, 2014

Video

Robert L. Fine, MD, an associate professor of Medicine at New York Presbyterian Hospital-Columbia University Medical Center, discusses a phase II study that evaluated the efficacy of neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX) in patients with inoperable pancreatic adenocarcinoma

Dr. Fine on Capecitabine Plus Temozolomide for NETs

January 17, 2014

Video

Robert L. Fine, MD, from the Columbia University Medical Center, discusses the prospective phase II study of CAPTEM for patients with neuroendocrine tumors.

x